close

Enter

Log in using OpenID

Global Radiopharmaceuticals Market

embed
According to a recent market research report released by Transparency Market Research, the global radiopharmaceuticals market is estimated to witness rapid expansion at a CAGR of 18.30% during the period between 2012 and 2018. The report, titled “Ra
Transparency Market Research
Global Radiopharmaceuticals Market: Growing Demand for Radiopharmaceuticals for
Cancer Treatment to Boost Market Expansion at 18.30% CAGR
Published Date
127 Page Report
20-Feb-2013
Request Sample
Buy Now
Press Release
http://www.transparencymarketresearch.com/pressrelease/radiopharmaceuticals-industry.htm
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
[email protected]
Breast Pumps Market
REPORT DESCRIPTION
Growing Demand for Radiopharmaceuticals for Cancer Treatment to Boost Market
Expansion at 18.30% CAGR
According to a recent market research report released by Transparency Market Research, the global radiopharmaceuticals
market is estimated to witness rapid expansion at a CAGR of 18.30% during the period between 2012 and 2018. The
report, titled “Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 2018”, projects the global radiopharmaceuticals market to reach a valuation of US$12.2 bn by 2018. The overall market
was worth US$3.8 bn in 2011.
The report points out that the growing preference for disease-specific therapy, especially radiopharmaceutical-based
cancer therapy, will boost the global radiopharmaceuticals market. Increasing awareness about accurate diagnosis,
coupled with expanding molecular imaging applications, will push the growth of the market during the forecast horizon.
However, the report mentions that strict regulatory guidelines for production, storage, and usage of radiopharmaceuticals
will hamper the growth of the global radiopharmaceuticals market. Worldwide supply shortages, along with price
sensitivity and the presence of competitive alternatives, will also negatively impact the overall market. The report states
that the increasing demand for accurate diagnosis and treatment, particularly in emerging markets, and the rise of
radiopharmaceutical-based personalized therapy will create new growth opportunities for the global radiopharmaceuticals
market.
Enquiry before Buying:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=
Overview of the companion diagnostics market
On the basis of type of radioactive isotope, the report segments the global radiopharmaceuticals market into Mo-99/Tc99m generators, Sr-82/Rb-82 generators, Ge-68/Ga-67,68 generators,
W-188/Re-188 generators, and Sr-90/Y-90
generators. So far, Mo-99/Tc-99m generators have dominated the overall market owing to their established marketing
2
Transparency Market Research
Breast Pumps Market
channels. However, during the forecast horizon, it is expected that other segments of the market will witness growth at
double-digit CAGRs.
Depending on application, the report categorizes the global radiopharmaceuticals market into diagnosis and therapy. The
usage of radiopharmaceuticals for diagnosis includes the techniques of SPECT and PET, wherein radiopharmaceuticals
are applied for the diagnosis of cardiovascular disorders, cancer, neurological disorders, thyroid diseases, and
gastrointestinal disorders. The usage of radiopharmaceuticals for therapy includes various isotopes used in oncology,
neurology, and cardiology. Oncology dominates the overall market for radiopharmaceuticals. While treating cancer, these
radioactive agents target the cancerous areas in the body to destroy the affected tissues.
Browse Full Press Release @
http://www.transparencymarketresearch.com/pressrelease/radiopharmaceuticals-industry.htm
TABLE OF CONTENT
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Global Radiopharmaceuticals Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Radiopharmaceutical-Based Cancer Therapy
3.2.2 Growing Preference For Disease-Targeted Therapy
3
Transparency Market Research
Breast Pumps Market
3.2.3 Increasing Awareness Of Accurate Diagnosis
3.2.4 Expanding Molecular Imaging Applications
3.3 Market Restraints
3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage
3.3.2 Worldwide Supply Shortages
3.3.3 Price Sensitivity And Competitive Alternatives
3.4 Market Opportunities
3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets
3.4.2 Radiopharmaceutical-Based Personalized Therapy
Chapter 4 Market Definition & Supply Chain Analysis
4.1 Market Definition
4.2 Radiopharmaceutical Production : A Global Perspective
4.3 Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market
5.1 Overview
5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
5.2 Mo-99/Tc-99m Generators
5.3 Sr-82/Rb-82 Generators
5.4 Ge-68/Ga-67,68 Generators
5.5 Sr-90/Y-90 Generators
5.6 W-188/Re-188 Generators
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
6.1 Overview
6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
6.2 Hospitals and Medical Centers
6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018
(USD Million)
6.3 Outpatient Diagnostic Centers
4
Transparency Market Research
Breast Pumps Market
6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)
Chapter 7 Global Radiopharmaceuticals Market, By Applications
7.1 Overview
7.2 Radiopharmaceuticals For Diagnosis
7.2.1 Overview
7.2.2 Radiopharmaceuticals For Diagnosis, By Technique
7.2.2.1 Single-Photon Emission Computed Tomography (SPECT)
7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
7.2.2.1.2 Technetium (Tc-99m)
7.2.2.1.3 Thallium (Tl-201)
7.2.2.1.4 Gallium (Ga-67)
7.2.2.1.5 Iodine (I-123)
7.2.2.1.6 Rhenium (Re-186)
7.2.2.1.7 Yttrium (Y-90)
7.2.2.1.8 Others
7.2.2.2 Positron Emission Tomography (PET)
7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
7.2.2.2.2 Fludeoxyglucose (18f-FDG)
7.2.2.2.3 Rubidium (Rb-82)
7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia)
7.2.3 Radiopharmaceuticals For Diagnosis, By Indications
7.2.3.1 Oncology
7.2.3.2 Cardiovascular
7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)
7.3 Radiopharmaceuticals For Therapy
7.3.1 Overview
7.3.2 Oncology (Systemic Therapy)
7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
7.3.2.2 Iodine (I-131)
7.3.2.3 Yttrium (Y-90)
5
Transparency Market Research
Breast Pumps Market
7.3.2.4 Samarium (Sm-153)
7.3.2.5 Strontium (Sr-89)
7.3.2.6 Rhenium (186Re)
7.3.2.7 Lutetium-177 (Lu-177)
7.3.2.8 Erbium-169 (169Er)
7.3.2.9 Others
7.3.3 Other Applications In Therapy (Cardiology, Neurology)
7.4 Theranostics
Chapter 8 Global Radiopharmaceuticals Market, By Geography
8.1 Overview
8.2 North America
8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.3 Europe
8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.4 Asia-Pacific (Apac)
8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.5 Rest of the World (RoW)
8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Chapter 9 Market Share Analysis By Key Players
9.1 Radiopharmaceuticals Market
9.2 Generators Market
Chapter 10 Recommendations
10.1 Identification and Elimination Of Barriers
10.2 Development of Total Solutions
6
Transparency Market Research
Breast Pumps Market
10.3 Investing in Emerging Markets
10.4 Entering Monopoly Markets
Chapter 11 Company Profiles
11.1 Cardinal Health Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Business Strategies
11.1.3.1 Mergers and Acquisitions
11.1.3.2 External Funding
11.1.3.3 Incorporation of Advanced Technologies to Support Business Development
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Covidien Plc
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Financial Overview
11.2.4 Strategic Overview
11.2.4.1 Mergers and Acquisitions
11.2.4.2 Approvals
11.2.5 Recent Developments
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Financial Overview
11.3.4 Strategic Overview
11.3.4.1 Mergers and Acquisitions
11.3.5 Recent Developments
11.4 IBA Group
11.4.1 Company Overview
11.4.2 Financial Overview
7
Transparency Market Research
Breast Pumps Market
11.4.3 Product Portfolio
11.5 Lantheus Medical Imaging
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Business Strategies
11.5.3.1 Rigorous Research and Development Initiatives
11.5.3.2 Selling Generic Products to Maintain Market Share
11.5.4 Product Portfolio
11.5.4.1 Recent Developments
11.6 Monrol Nuclear Products, Inc.
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Strategic Overview
11.6.3.1 Mergers and Acquisitions
11.6.3.2 Collaborations
11.6.4 Recent Developments
11.7 Nordion, Inc.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Financial Overview
11.7.4 Strategic Overview
11.7.4.1 Contracts and Agreements
11.7.4.2 Divestiture
11.7.5 Recent Developments
11.7.5.1 New Product Launch
11.8 NTP Radioisotopes (Pty) Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Business Strategies
11.8.3.1 Media Campaigns as a Brand Management Tool
11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances
8
Transparency Market Research
Breast Pumps Market
11.8.4 Product Portfolio
11.8.5 Recent Developments
11.9 Polatom
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Business Strategies
11.9.3.1 Maintaining an Extensive Network of Distributors
11.9.4 Product Portfolio
11.9.5 Recent Developments
11.10 Positron Corporation
11.10.1 Company Overview
11.10.2 Product Portfolio
11.10.3 Financial Overview
11.10.4 Strategic Overview
11.10.4.1 Contracts and Agreements
11.10.4.2 Collaborations
11.10.5 Recent Developments
11.10.5.1 Grants and Licenses
11.10.5.2 Incentives
11.11 Siemens Healthcare
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Business Strategies
11.11.3.1 Investing In Emerging Economies
11.11.3.2 Rigorous Research and Development Initiatives
11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013)
11.11.3.4 Maintaining An Extensive Suppliers Network
11.11.4 Product Portfolio
11.11.5 Recent Developments
9
Transparency Market Research
Breast Pumps Market
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and
consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical,
chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR
research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape,
detailed segmentation, key trends, and strategic recommendations.
Contact
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
10
Transparency Market Research
Author
Priya
Priya45   documents Email
Document
Category
Health and Medicine
Views
11
File Size
475 KB
Tags
global, Global Radiopharmaceuticals Market
1/--pages
Report inappropriate content